Research Interests
Aged Health Care Agricultural Spatial Analysis and Modelling Agricultural Systems Analysis and Modelling Antimicrobial Resistance Applied Statistics Artificial Intelligence Autoimmunity Bioinformatics Biostatistics Cancer Genetics Genetics Health Informatics Health Policy Medical and Health Sciences Medical Genetics Medical Informatics Panel Data Analysis Pattern Recognition and Data Mining Pharmaceutical Sciences Pharmacogenomics Population Health Public Health Public Health and Health Services StatisticsMax Moldovan
School of Agriculture, Food and Wine
Faculty of Sciences, Engineering and Technology
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Max Moldovan, PhD is an applied statistician/data scientist working in the fields of methodological research and data analysis in life sciences. Max obtained his PhD in statistics from the University of Melbourne in 2008, followed by the postdoctoral training in the Walter and Eliza Hall Research Institute of Medical Research (WEHI). Over his career, Max led and contributed to various research projects with a major tangible impact nationally and internationally. Since 2014 and before joining the Biometry Hub in July 2021, Max was employed firstly as a Lead Bioinformatician and later as a Senior Data Scientist by the South Australian Health and Medical Research Institute (SAHMRI), where he was a recipient of the Research Translation Award and High-impact Publication Award, in 2019 and 2020, respectively.For the current research and methodological interests, Max is particularly interested in exact, unbiased and efficient inference, including causal inference, from observational and routinely collected datasets, related statistical learning methods and generalised additive modelling approaches.
| Date | Position | Institution name |
|---|---|---|
| 2016 - 2021 | Bioinformatician/Senior Data Scientist | South Australian Health and Medical Research Institute |
| 2014 - 2016 | Senior Research Fellow | University of South Australia |
| 2010 - 2013 | Research Fellow | UNSW Australia |
| 2008 - 2010 | Postdoctoral Fellow | Walter and Eliza Hall Institute of Medical Research |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2005 - 2008 | University of Melbourne | Australia | PhD |
| 2001 - 2003 | Queensland University of Technology | Australia | Master of Business (research) |
| Year | Citation |
|---|---|
| 2024 | Sluggett, J. K., Caughey, G. E., Air, T., Lang, C., Moldovan, M., Martin, G., . . . Inacio, M. C. (2024). Health outcomes following provision of Home Medicines Reviews for older people receiving aged care services at home. Research in Social and Administrative Pharmacy, 20(11), 1064-1069. Scopus1 WoS1 Europe PMC1 |
| 2023 | Eshetie, T. C., Moldovan, M., Caughey, G. E., Lang, C., Sluggett, J. K., Khadka, J., . . . Inacio, M. C. (2023). Development of a Multivariable Prediction Model for Risk of Hospitalization With Pressure Injury After Entering Residential Aged Care. Journal of the American Medical Directors Association (JAMDA): long-term care: management, applied research and clinical issues, 24(3), 299-306.e9. Scopus4 WoS4 Europe PMC3 |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Data from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2022 | Nechval, N. A., Berzins, G., Nechval, K. N., Tsaurkubule, Z., & Moldovan, M. (2022). A New Intelligent Method for Eliminating Unknown (Nuisance) Parameters from Underlying Models as an Alternative to the Bayesian Approach. Journal of Applied Mathematics and Computation, 6(1), 53-65. |
| 2022 | Sluggett, J. K., Caughey, G. E., Air, T., Moldovan, M., Lang, C., Martin, G., . . . Inacio, M. C. (2022). Medicines use before and after comprehensive medicines review among residents of long-term care facilities: a retrospective cohort study. BMC Geriatrics, 22(1), 493-1-493-15. Scopus18 WoS17 Europe PMC15 |
| 2022 | Sluggett, J. K., Caughey, G. E., Air, T., Moldovan, M., Lang, C., Martin, G., . . . Inacio, M. C. (2022). Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study. Age and Ageing, 51(7), 1-11. Scopus15 WoS15 Europe PMC13 |
| 2022 | Centenera, M. M., Vincent, A. D., Moldovan, M., Lin, H. M., Lynn, D. J., Horvath, L. G., & Butler, L. M. (2022). Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants. Cancers, 14(7), 1-18. Scopus13 WoS12 Europe PMC15 |
| 2021 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S., . . . Swinnen, J. V. (2021). Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Research, 81(19), 4981-4993. Scopus62 WoS59 Europe PMC59 |
| 2021 | Jiang, S. H., Mercan, S., Papa, I., Moldovan, M., Walters, G. D., Koina, M., . . . Vinuesa, C. G. (2021). Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease.. Cell reports. Medicine, 2(12), 14 pages. Scopus8 WoS6 Europe PMC7 |
| 2021 | Sluggett, J. K., Moldovans, M., Lang, C., Lynn, D. J., Papanicolas, L. E., Crotty, M., . . . Inacio, M. C. (2021). Contribution of facility level factors to variation in antibiotic use in long-term care facilities: a national cohort study. The Journal of Apyntimicrobial Chemothera, 76(5), 1339-1348. Scopus13 WoS12 Europe PMC10 |
| 2021 | Sluggett, J. K., Moldovan, M., Lynn, D. J., Papanicolas, L. E., Crotty, M., Whitehead, C., . . . Inacio, M. C. (2021). National trends in antibiotic Use in Australian residential aged care facilities, 2005-2016. Clinical Infectious Diseases, 72(12), 2167-2174. Scopus17 WoS10 Europe PMC18 |
| 2021 | Gillis, J. L., Hinneh, J. A., Ryan, N. K., Irani, S., Moldovan, M., Quek, L. -E., . . . Butler, L. M. (2021). A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. eLife, 10, e62592-1-e62592-27. Scopus27 WoS25 Europe PMC29 |
| 2021 | Inacio, M. C., Moldovan, M., Whitehead, C., Sluggett, J. K., Crotty, M., Corlis, M., . . . Caughey, G. E. (2021). The risk of fall-related hospitalisations at entry into permanent residential aged care. BMC Geriatrics, 21(1), 686-1-686-13. Scopus21 WoS21 Europe PMC14 |
| 2020 | Moldovan, M., Khadka, J., Visvanathan, R., Wesselingh, S., & Inacio, M. C. (2020). Using elastic nets to estimate frailty burden from routinely collected national aged care data. Journal of the American Medical Informatics Association, 27(3), 419-428. Scopus12 WoS12 Europe PMC11 |
| 2020 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2020). Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by heat shock protein 90 inhibition. Molecular cancer research : MCR, 18(10), 1500-1511. Scopus19 WoS18 Europe PMC19 |
| 2020 | Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J., Irani, S., Centenera, M. M., . . . Butler, L. M. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife, 9, 1-34. Scopus151 WoS146 Europe PMC150 |
| 2020 | Khadka, J., Visvanathan, R., Theou, O., Moldovan, M., Amare, A. T., Lang, C., . . . Inacio, M. C. (2020). Development and validation of a frailty index based on Australian Aged Care Assessment Program data. Medical Journal of Australia, 213(7), 321-326. Scopus28 WoS28 Europe PMC25 |
| 2020 | Tomita, Y., Moldovan, M., Chang Lee, R., Hsieh, A. H., Townsend, A., & Price, T. (2020). Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma. The Cochrane database of systematic reviews, 2020(11), 121 pages. Scopus3 Europe PMC14 |
| 2020 | Tomita, Y., Moldovan, M., Lee, R. C., Hsieh, A. H. C., Townsend, A., & Price, T. (2020). Salvage systemic therapy for advanced gastric and oesophagogastric junction adenocarcinoma. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11), 122 pages. WoS14 |
| 2019 | Charitou, T., Srihari, S., Lynn, M. A., Jarboui, M. A., Fasterius, E., Moldovan, M., . . . Lynn, D. J. (2019). Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS<sup>G13D</sup> mutation. British Journal of Cancer, 121(1), 37-50. Scopus43 WoS44 Europe PMC44 |
| 2019 | Ryan, F. J., Drew, D. P., Douglas, C., Leong, L. E. X., Moldovan, M., Lynn, M., . . . Lynn, D. J. (2019). Changes in the composition of the gut microbiota and the blood transcriptome in preterm infants at less than 29 weeks gestation diagnosed with bronchopulmonary dysplasia. mSystems, 4(5), e00484-19-1-e00484-19-17. Scopus37 WoS33 Europe PMC32 |
| 2019 | Schmidt, A. F., Holmes, M. V., Preiss, D., Swerdlow, D. I., Denaxas, S., Fatemifar, G., . . . Dehghan, A. (2019). Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovascular Disorders, 19(1), 10 pages. Scopus28 WoS22 Europe PMC32 |
| 2019 | Nassar, Z., Mah, C. Y., Dehairs, J., Burvenich, I. J. G., Irani, S., Centenera, M., . . . Butler, L. (2019). DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. |
| 2019 | Liu, Y. C., Nguyen, P. A., Humayun, A., Chien, S. C., Yang, H. C., Asdary, R. N., . . . Iqbal, U. (2019). Does long-term use of antidiabetic drugs changes cancer risk?. Medicine (United States), 98(40), 9 pages. Scopus29 WoS24 Europe PMC17 |
| 2018 | Armstrong, H., Gillis, J., Johnson, I., Nassar, Z., Moldovan, M., Levrier, C., . . . Butler, L. (2018). Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion. Scientific reports, 8(1), 2090-1-2090-14. Scopus32 WoS32 Europe PMC30 |
| 2018 | Dent, E., Hoogendijk, E., & Moldovan, M. (2018). Frailty index from routine laboratory measurements correlates with leukocyte telomere length. Geriatrics and Gerontology International, 18(4), 654-655. Scopus6 WoS4 Europe PMC5 |
| 2018 | Nguyen, E., Centenera, M., Moldovan, M., Das, R., Irani, S., Vincent, A., . . . Butler, L. (2018). Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants. Molecular & cellular proteomics : MCP, 17(8), 1470-1486. Scopus28 WoS30 Europe PMC29 |
| 2017 | Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., . . . Völker, U. (2017). PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes and Endocrinology, 5(2), 97-105. Scopus317 WoS293 Europe PMC283 |
| 2017 | Dale, C., Fatemifar, G., Palmer, T., White, J., Prieto-Merino, D., Zabaneh, D., . . . Casas, J. (2017). Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation, 135(24), 2373-2388. Scopus290 WoS279 Europe PMC279 |
| 2017 | Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., . . . King, C. (2017). Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study. Pharmacogenomics Journal, 17(4), 312-318. Scopus26 WoS24 Europe PMC24 |
| 2017 | Iqbal, U., Chang, T. H., Nguyen, P. A., Syed-Abdul, S., Yang, H. C., Huang, C. W., . . . Li, Y. C. (2017). Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence. Journal of Biomedical Informatics, 74, 85-91. Scopus5 WoS5 Europe PMC4 |
| 2016 | Jacobsen, R., Moldovan, M., Vaag, A. A., Hypponen, E., & Heitmann, B. L. (2016). Erratum: Vitamin D fortification and seasonality of birth in type 1 diabetic cases: D-tect study (Journal of Developmental Origins of Health and Disease (2016) 7 (114-119) DOI: 10.1017/S2040174415007849). Journal of Developmental Origins of Health and Disease, 7(4), 429. Scopus3 |
| 2016 | Larsen, S. C., Ängquist, L., Moldovan, M., Huikari, V., Sebert, Y., Cavadino, A., . . . Sørensen, T. I. A. (2016). Serum 25-hydroxyvitamin D status and longitudinal changes in weight and waist circumference: Influence of genetic predisposition to adiposity. PLoS ONE, 11(4), 1-18. Scopus10 WoS10 Europe PMC7 |
| 2016 | Jacobsen, R., Moldovan, M., Vaag, A. A., Hypponen, E., & Heitmann, B. L. (2016). Vitamin D fortification and seasonality of birth in type 1 diabetic cases: D-tect study. Journal of Developmental Origins of Health and Disease, 7(1), 114-119. Scopus13 Europe PMC10 |
| 2015 | Syed-Abdul, S., Moldovan, M., Nguyen, P. A., Enikeev, R., Jian, W. S., Iqbal, U., . . . Li, Y. C. (2015). Profiling phenome-wide associations: A population-based observational study. Journal of the American Medical Informatics Association, 22(4), 896-899. Scopus6 WoS4 Europe PMC6 |
| 2014 | Davey Smith, G., Hyppönen, E., Moldovan, M., & Power, C. (2014). Death of siblings in childhood and subsequent mortality: prospective observational study. European Journal of Epidemiology, 29(11), 859-861. Scopus2 WoS2 Europe PMC2 |
| 2014 | Moldovan, M., Enikeev, R., Syed-Abdul, S., Nguyen, P. A., Chang, Y. C., & Li, Y. C. (2014). Disease universe: Visualisation of population-wide disease-wide associations. Advances in Systems Science and Applications, 14(2), 144-158. Scopus4 |
| 2014 | Moldovan, M., & Langaas, M. (2014). Exact conditional efficiency robust P-values from an arbitrary ranking of a sample space: An application to genome-wide association studied. Advances in Systems Science and Applications, 14(1), 79-86. Scopus1 |
| 2013 | Shaw, C. D., Braithwaite, J., Moldovan, M., Nicklin, W., Grgic, I., Fortune, T., & Whittaker, S. (2013). Profiling health-care accreditation organizations: An international survey. International Journal for Quality in Health Care, 25(3), 222-231. Scopus69 WoS60 Europe PMC48 |
| 2013 | Mumford, V., Greenfield, D., Hinchcliff, R., Moldovan, M., Forde, K., Westbrook, J. I., & Braithwaite, J. (2013). Economic evaluation of Australian acute care accreditation (ACCREDIT-CBA (Acute)): Study protocol for a mixedmethod research project. BMJ Open, 3(2), 8 pages. Scopus18 WoS16 Europe PMC13 |
| 2013 | Mahurkar, S., Moldovan, M., Suppiah, V., & O'Doherty, C. (2013). Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment. Plos One, 8(2), 9 pages. Scopus19 WoS20 Europe PMC18 |
| 2012 | Braithwaite, J., Shaw, C. D., Moldovan, M., Greenfield, D., Hinchcliff, R., Mumford, V., . . . Whittaker, S. (2012). Comparison of health service accreditation programs in low- and middle-income countries with those in higher income countries: A cross-sectional study. International Journal for Quality in Health Care, 24(6), 568-577. Scopus52 WoS46 Europe PMC35 |
| 2012 | Greenfield, D., Hinchcliff, R., Moldovan, M., Mumford, V., Pawsey, M., Westbrook, J. I., & Braithwaite, J. (2012). A multimethod research investigation of consumer involvement in Australian health service accreditation programmes: The ACCREDIT-SCI study protocol. BMJ Open, 2(5), 7 pages. Scopus16 WoS11 Europe PMC13 |
| 2012 | Hinchcliff, R., Greenfield, D., Moldovan, M., Westbrook, J. I., Pawsey, M., Mumford, V., & Braithwaite, J. (2012). Narrative synthesis of health service accreditation literature. BMJ Quality and Safety, 21(12), 979-991. Scopus157 WoS140 Europe PMC110 |
| 2012 | Greenfield, D., Pawsey, M., Hinchcliff, R., Moldovan, M., & Braithwaite, J. (2012). The standard of healthcare accreditation standards: A review of empirical research underpinning their development and impact. BMC Health Services Research, 12(1), 14 pages. Scopus78 WoS67 Europe PMC55 |
| 2012 | Hinchcliff, R., Greenfield, D., Moldovan, M., Pawsey, M., Mumford, V., Westbrook, J. I., & Braithwaite, J. (2012). Evaluation of current Australian health service accreditation processes (ACCREDIT-CAP): Protocol for a mixed-method research project. BMJ Open, 2(4), 7 pages. Scopus17 WoS12 Europe PMC15 |
| 2012 | Greenfield, D., Hinchcliff, R., Westbrook, M., Jones, D., Low, L., Johnston, B., . . . Braithwaite, J. (2012). An empirical test of accreditation patient journey surveys: Randomized trial. International Journal for Quality in Health Care, 24(5), 495-500. Scopus16 WoS15 Europe PMC14 |
| 2012 | Hinchcliff, R., Westbrook, J., Greenfield, D., Baysari, M., Moldovan, M., & Braithwaite, J. (2012). Analysis of Australian newspaper coverage of medication errors. International Journal for Quality in Health Care, 24(1), 1-8. Scopus13 WoS12 Europe PMC13 |
| 2012 | Greenfield, D., Moldovan, M., Westbrook, M., Jones, D., Low, L., Johnston, B., . . . Braithwaite, J. (2012). An empirical test of short notice surveys in two accreditation programmes. International Journal for Quality in Health Care, 24(1), 65-71. Scopus27 WoS26 Europe PMC22 |
| 2012 | Nechval, K. N., Nechval, N. A., Purgailis, M., Rozevskis, U., Strelchonok, V. F., & Moldovan, M. (2012). Predictive inferences for a future number of failures coming from underlying models under parametric uncertainty. Advances in Systems Science and Applications, 12(4), 373-387. |
| 2011 | Braithwaite, J., Westbrook, J., Johnston, B., Clark, S., Brandon, M., Banks, M., . . . Moldovan, M. (2011). Strengthening organizational performance through accreditation research-a framework for twelve interrelated studies: The ACCREDIT project study protocol. BMC Research Notes, 4(1), 390. Scopus36 Europe PMC27 |
| 2011 | Lloyd, C. J., & Moldovan, M. V. (2011). Constructing more powerful exact tests of equivalence from binary matched pairs. Australian and New Zealand Journal of Statistics, 53(1), 27-42. Scopus4 WoS3 |
| 2009 | Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., . . . George, J. (2009). IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nature Genetics, 41(10), 1100-1104. Scopus1754 WoS1584 Europe PMC1400 |
| 2008 | Lloyd, C. J., & Moldovan, M. V. (2008). A more powerful exact test of noninferiority from binary matched-pairs data. Statistics in Medicine, 27(18), 3540-3549. Scopus32 WoS30 Europe PMC16 |
| 2007 | Lloyd, C. J., & Moldovan, M. V. (2007). Exact one-sided confidence bounds for the risk ratio in 2 × 2 tables with structural zero. Biometrical Journal, 49(6), 952-963. Scopus8 WoS5 Europe PMC3 |
| 2007 | Lloyd, C. J., & Moldovan, M. V. (2007). Unconditional efficient one-sided confidence limits for the odds ratio based on conditional likelihood. Statistics in Medicine, 26(28), 5136-5146. Scopus15 WoS11 Europe PMC4 |
| 2007 | Lloyd, C. J., & Moldovan, M. V. (2007). Exact one-sided confidence limits for the difference between two correlated proportions. Statistics in Medicine, 26(18), 3369-3384. Scopus18 WoS16 Europe PMC8 |
| - | Moldovan, M., Radbone, C., & Inacio, M. C. (2020). Benchmarking Computational Performance of Virtual Machines Within the Secure Unified Research Environment Versus Physical Computers. International Journal of Population Data Science, 5(5). |
| - | Moldovan, M., & Taylor, J. (2022). Elastic Net (Model Selection). Unknown Journal, 1-5. |
| Year | Citation |
|---|---|
| 2020 | Sluggett, J. K., Moldovan, M., Lynn, D. J., Papanicolas, L., Crotty, M., Whitehead, C., . . . Inacio, M. C. (2020). National Trends in Antibiotic Use in Australian Residential Aged Care Facilities, 2005-2016. In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY Vol. 68 (pp. S143). Long Beach, CA: WILEY. WoS10 |
| 2013 | Nechval, N. A., Nechval, K. N., Purgailis, M., Rozevskis, U., Danovich, V., Ribakova, N., . . . Moldovan, M. (2013). Solving the problems of inspection planning under parametric uncertainty of underlying models. In IFAC Proceedings Volumes IFAC Papersonline Vol. 46 (pp. 489-494). Elsevier BV. DOI |
| 2009 | Moldovan, M., Suppiah, V., Booth, D., George, J., & Bahlo, M. (2009). Prediction Modeling in the Context of Pharmacogenomic Genome-wide Association Study: Identifying Non-responders to PegINF-alpha/ribavirin Treatment Among Chronic Genotype 1 Hepatitis C Virus Infected Individuals. In GENETIC EPIDEMIOLOGY Vol. 33 (pp. 808). Honolulu, HI: WILEY-LISS. |
| Year | Citation |
|---|---|
| 2020 | Mah, C. Y., Nassar, Z. D., Burvenich, I. J., Irani, S., Centenera, M. M., Moldovan, M., . . . Butler, L. M. (2020). DECR1: The rate limiting enzyme of polyunsaturated fatty acid metabolism and a novel therapeutic target in prostate cancer. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH. DOI |
| 2018 | Dent, E., Hoogendijk, E., & Moldovan, M. (2018). Telomere length associates with a Frailty Index Based on Standard Laboratory Measurements (FI-LAB). Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY. |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Principal Supervisor | Causal learning for optimising industry relevant traits in Australian grain production systems | Doctor of Philosophy | Doctorate | Full Time | Mr Aidan James Moller |
Connect With Me
External Profiles
